Combotope Therapeutics
Pre-clinicalCrystal structure revealing how Combotope antibodies specifically binds cancer-specific Tn-glycoprotein epitopes
Founded
2018
Focus
OncologyImmunology
About
Crystal structure revealing how Combotope antibodies specifically binds cancer-specific Tn-glycoprotein epitopes
Funding History
1Total raised: $5.5M
Seed$5.5MNovo HoldingsJun 15, 2022
Company Info
TypePrivate
Founded2018
LocationCopenhagen, Denmark
StagePre-clinical
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile